Dexuan Yang

406 total citations
15 papers, 328 citations indexed

About

Dexuan Yang is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Dexuan Yang has authored 15 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Dexuan Yang's work include Synthesis and biological activity (2 papers), Quinazolinone synthesis and applications (2 papers) and Cancer Treatment and Pharmacology (2 papers). Dexuan Yang is often cited by papers focused on Synthesis and biological activity (2 papers), Quinazolinone synthesis and applications (2 papers) and Cancer Treatment and Pharmacology (2 papers). Dexuan Yang collaborates with scholars based in China, United States and Taiwan. Dexuan Yang's co-authors include Shoujun Yuan, Linna Li, Chengwang Xu, Wanjun Guo, Lin Wang, Huadong Zhang, Zhixian Sun, Fang Guan, Lan Xie and Qi Zhang and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Dexuan Yang

14 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dexuan Yang China	9	176	71	60	55	52	15	328
Yongping Cui China	5	228 1.3×	40 0.6×	99 1.6×	56 1.0×	28 0.5×	10	437
Hossain Ahmed Bangladesh	3	210 1.2×	49 0.7×	136 2.3×	85 1.5×	48 0.9×	6	450
Archana Katoch India	14	214 1.2×	35 0.5×	98 1.6×	55 1.0×	33 0.6×	19	345
Małgorzata Kajstura United States	4	226 1.3×	46 0.6×	79 1.3×	68 1.2×	14 0.3×	7	379
Felix Kopp United States	4	243 1.4×	81 1.1×	44 0.7×	37 0.7×	14 0.3×	5	348
Hon Yan Kelvin Yip Australia	7	177 1.0×	58 0.8×	106 1.8×	56 1.0×	15 0.3×	9	321
Sai-Peng Sim Malaysia	5	351 2.0×	52 0.7×	149 2.5×	46 0.8×	42 0.8×	10	461
Zheyuan Xu China	11	192 1.1×	42 0.6×	95 1.6×	62 1.1×	33 0.6×	27	409
Soo‐Yeon Hwang South Korea	10	220 1.3×	57 0.8×	115 1.9×	66 1.2×	20 0.4×	22	374
Mir Mohd Faheem India	13	186 1.1×	36 0.5×	95 1.6×	53 1.0×	15 0.3×	18	327

Countries citing papers authored by Dexuan Yang

Since Specialization

Citations

This map shows the geographic impact of Dexuan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dexuan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dexuan Yang more than expected).

Fields of papers citing papers by Dexuan Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dexuan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dexuan Yang. The network helps show where Dexuan Yang may publish in the future.

Co-authorship network of co-authors of Dexuan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Dexuan Yang. A scholar is included among the top collaborators of Dexuan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dexuan Yang. Dexuan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Yan, Junyu, Dexuan Yang, Wangjun Liao, et al.. (2021). A Modified Surgical Ventricular Reconstruction in Post-infarction Mice Persistently Alleviates Heart Failure and Improves Cardiac Regeneration. Frontiers in Cardiovascular Medicine. 8. 789493–789493. 4 indexed citations

Morris‐Natschke, Susan L., Keduo Qian, Xiaofeng Wang, et al.. (2020). Optimization of 4-( N -Cycloamino)phenylquinazolines as a Novel Class of Tubulin-Polymerization Inhibitors Targeting the Colchicine Site. Figshare.

Yang, Jun, Linna Li, Chengwang Xu, et al.. (2018). CT‑1042, a novel anticancer agent, exhibits effects by activating p53 and inhibiting survivin. Oncology Reports. 39(6). 2759–2768. 4 indexed citations

Wang, Ying, Shoujun Yuan, Linna Li, et al.. (2017). Novel proapoptotic agent SM-1 enhances the inhibitory effect of 5-fluorouracil on colorectal cancer cells in vitro and in vivo. Oncology Letters. 13(6). 4762–4768. 5 indexed citations

Guan, Fang, Rui Ding, Qi Zhang, et al.. (2017). WX-132-18B, a novel microtubule inhibitor, exhibits promising anti-tumor effects. Oncotarget. 8(42). 71782–71796. 28 indexed citations

Zhang, Qi, et al.. (2016). Preclinical pharmacodynamic evaluation of antibiotic nitroxoline for anticancer drug repurposing. Oncology Letters. 11(5). 3265–3272. 28 indexed citations

Zou, Pan, Xin Yang, Yanxin Zhang, et al.. (2016). Antitumor Effects of Orally and Intraperitoneally Administered Chitosan Oligosaccharides (COSs) on S180‐Bearing/Residual Mouse. Journal of Food Science. 81(12). H3035–H3042. 27 indexed citations

Guo, Wanjun, Linna Li, Chengwang Xu, et al.. (2015). Micheliolide Derivative DMAMCL Inhibits Glioma Cell Growth In Vitro and In Vivo. PLoS ONE. 10(2). e0116202–e0116202. 62 indexed citations

Zhang, Hui, Wei Gong, Zhiyuan Wang, et al.. (2014). Preparation, Characterization, and Pharmacodynamics of Thermosensitive Liposomes Containing Docetaxel. Journal of Pharmaceutical Sciences. 103(7). 2177–2183. 34 indexed citations

10.

Li, Linna, Dexuan Yang, Jia Na, et al.. (2014). Anticancer activity of tuftsin-derived T peptide in postoperative residual tumors. Anti-Cancer Drugs. 25(8). 857–867. 12 indexed citations

11.

Wang, Xiao Feng, Fang Guan, Emika Ohkoshi, et al.. (2014). Optimization of 4-(N-Cycloamino)phenylquinazolines as a Novel Class of Tubulin-Polymerization Inhibitors Targeting the Colchicine Site. Journal of Medicinal Chemistry. 57(4). 1390–1402. 61 indexed citations

12.

Xuan, Zixue, Qi Zhang, Chengwang Xu, et al.. (2014). Fully human VEGFR2 monoclonal antibody BC001 attenuates tumor angiogenesis and inhibits tumor growth. International Journal of Oncology. 45(6). 2411–2420. 10 indexed citations

13.

Xuan, Zixue, et al.. (2013). Exploration of the Protection of Riboflavin Laurate on Oral Mucositis Induced by Chemotherapy or Radiotherapy at the Cellular Level: What Is the Leading Contributor?. International Journal of Molecular Sciences. 14(3). 4722–4733. 4 indexed citations

14.

Wang, Yanliang, Yuxin Lu, Xiaochen Cheng, et al.. (2009). Microbial transformation of epothilone A byAspergillus nigerAS 3.739. Journal of Asian Natural Products Research. 11(4). 357–364. 6 indexed citations

15.

Zhang, Huadong, et al.. (2008). Differential sensitivity of colorectal cancer cell lines to artesunate is associated with expression of beta-catenin and E-cadherin. European Journal of Pharmacology. 588(1). 1–8. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact